1. Zong L, Abe M, Seto Y, Ji J. The challenge of screening for early gastric cancer in China. Lancet. 2016;388(10060):2606.(IF=44.002)

2. Yu Zhang ，Di Zhang ，Qian Li，Jing Liang，Luyang Sun，Xia Yi，ZheChen，Ruorong Yan，Guojia Xie，Wanjin Li，Shumeng Liu，Bosen Xu，LeiLi，Jianguo Yang，Lin He，Yongfeng Shang，Nucleation of DNA repair factors byFOXA1 links DNA demethylation to transcriptional pioneering，Nature Genetics，2016.9.01，48(9)：1003~1013(31.616)

3. Lin Shan ，Xing Zhou，Xinhua Liu，Yue Wang，Dongxue Su，YongqiangHou，Na Yu，Chao Yang，Beibei Liu，Jie Gao，Yang Duan，Jianguo Yang，WanjinLi，Jing Liang，Luyang Sun，Kexin Chen，Chenghao Xuan，Lei Shi，Yan Wang，Yongfeng Shang，FOXK2 elicits massive transcription repression and suppresses thehypoxic response and breast cancer carcinogenesis，Cancer Cell，2016.11.14，30(5)：708~722(23.214)

4. Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Chen P, Liu H, Zheng C, Liu F, Yu J, Li Z, Zhao G, Chen X, Wang K, Li P, Xing J, Li G. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. J Clin Oncol. 2016;34(12):1350-7.(IF=20.982)

5. Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, Wang JX, Zhang L, Zhang Y, Bajbouj M, Zhang LF, Li M, Vieth M, Liu RY, Quante M, Wang LH, Suchanek S, Zhou T, Guan WX, Schmid R, Classen M, You WC. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut. 2016;65(1):9-18(IF=14.921)

6. Wang Y, Zhang N, Zhang L, Li R, Fu W, Ma K, Li X, Wang L, Wang J, Zhang H, Gu W, Zhu WG, Zhao Y.Autophagy Regulates Chromatin Ubiquitination in DNA Damage Response through Elimination of SQSTM1/p62. Mol Cell. 2016 Jul 7;63(1):34-48.(IF=13.958)

7. Lei Li ，Lan Shi ，Shangda Yang，Ruorong Yan，Di Zhang，JianguoYang，Lin He，Wanjin Li，Xia Yi，Luyang Sun，Jing Liang，Zhongyi Cheng，LeiShi，Yongfeng Shang，Wenhua Yu，SIRT7 is a histone desuccinylase thatfunctionally links to chromatin compaction and genome stability，Nature Communications，2016.7.20，7：12235~12235(11.329)

8. Yang Duan ，Dawei Huo，Jie Gao，Heng Wu，Zheng Ye，Zhe Liu，KaiZhang，Lin Shan，Xing Zhou，Yue Wang，Dongxue Su，Xiang Ding，Lei Shi，YanWang，Yongfeng Shang，Chenghao Xuan，Ubiquitin ligase RNF20/40 facilitatesspindle assembly and promotes breast carcinogenesis through stabilizing motorprotein Eg5，Nature Communications，2016.8.25，7：12648~12648(11.329)

9. Wang Y, Zhu WG, Zhao Y. Autophagy substrate SQSTM1/p62 regulates chromatin ubiquitination during the DNA damage response. Autophagy. 2017 Jan 2;13(1):212-213.(IF=9.108)

10. Kong Y, Si L, Li Y, Wu X, Xu X, Dai J, Tang H, Ma M, Chi Z, Sheng X, Cui C, Guo J. Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors. Clin Cancer Res. 2016;22(4):1018-27.(IF=8.738)

11. Meng Y, Wang L, Chen D, Chang Y, Zhang M, Xu JJ, Zhou R, Zhang QY. LAPTM4B: an oncogene in various solid tumors and its functions. Oncogene. 2016;35(50):6359-6365.(IF=7.932)

12. Xing R, Li L, Chen L, Gao Z, Wang H, Li W, Cui J, Tian G, Liang Q, Yu J, Sung JJ, Luo G, Gao H, Xu X, Yang H, Wang J, Zhang X, Wang JM, Huang J, Yu Y, Wang J, Lu Y. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells. Oncogene. 2016;35(20):2584-91.(IF=7.932)

13. Cao LL, Wei F, Du Y, Song B, Wang D, Shen C, Lu X, Cao Z, Yang Q, Gao Y, Wang L, Zhao Y, Wang H, Yang Y, Zhu WG. ATM-mediated KDM2A phosphorylation is required for the DNA damage repair. Oncogene. 2016;35(3):301-13.(IF=7.932)

14. Chen Z, Zhang C, Pan Y, Xu R, Xu C, Chen Z, et al. T cell receptor beta-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma. J Pathol. 2016 Aug;239(4):450-8.(IF=7.381)

15. Lu Z, Sheng J, Zhang Y, Deng J, Li Y, Lu A, Zhang J, Yu H, Zhang M, Xiong Z, Yan H, Diplas BH, Lu Y, Liu B. Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles. J Pathol. 2016;239(1):72-83.(IF=7.381)

16. Pan Y, Lin S, Xing R, Zhu M, Lin B, Cui J, Li W, Gao J, Shen L, Zhao Y, Guo M, Wang JM, Huang J, Lu Y. Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation. Antioxid Redox Signal. 2016;24(15):839-54.(IF=7.093)

17. Deng Q, Li J, Pan Y, Liu F, He Z, Liu M, Liu Y, Zhang C, Abliz A, Shen N, Hang D, Xu Z, Wang Q, Ning T, Guo C, Liang Y, Xu R, Zhang L, Cai H, Ke Y. Prevalence and Associated Risk Factors of Human Papillomavirus in Healthy Skin Specimens Collected from Rural Anyang, China, 2006-2008. J Invest Dermatol. 2016;136(6):1191-8.(IF=6.915)

18. Wang S, Mei XG, Goldberg SN, Ahmed M, Lee JC, Gong W, Han HB, Yan K, Yang W. Does Thermosensitive Liposomal Vinorelbine Improve End-Point Survival after Percutaneous Radiofrequency Ablation of Liver Tumors in a Mouse Model? Radiology. 2016;279(3):762-72.(IF=6.798)

19. Wang S, Tsui ST, Liu C, Song Y, Liu D. EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancer. J Hematol Oncol. 2016;9(1):59.(IF=6.263)

20. Wang S, Cang S, Liu D. Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer. J Hematol Oncol. 2016;9:34.(IF=6.263)

21. Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, Chi Z, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Dai J, Guo J. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. Eur J Cancer. 2016;65:156-63.(IF=6.163)

22. Zhang SY, Zhu GY, Li G, Zhang YB, Geng JH. Application of stereotactic body radiation therapy to cancer liver metastasis. Cancer Lett. 2016;379(2):225-9.(IF=5.992)

23. Shan F, Miao R, Xue K, Li Z, Li Z, Bu Z, Wu A, Zhang L, Wu X, Zong X, Wang X, Li S, Ji X, Jia Z, Li Z, Ji J. Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials. Cancer Lett. 2016;380(2):598-607(IF=5.992)

24. Wang Q, Zhang X, Shen E, Gao J, Cao F, Wang X, Li Y, Tian T, Wang J, Chen Z, Wang J, Shen L. The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer. Cancer Lett. 2016;80(1):20-30. (IF=5.992)

25. Humphrey ES, Su SP, Nagrial AM, Hochgr?fe F, Pajic M, Lehrbach GM, Parton RG, Yap AS, Horvath LG, Chang DK, Biankin AV, Wu J, Daly RJ. Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016;15(8):2671-85. (IF=5.912)

26. Li N, Wang X, Lin B, Zhu H, Liu C, Xu X, Zhang Y, Zhai S, OuYang T, Li J, Yang Z. Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients. J Nucl Med. 2016;57(8):1214-20.(IF=5.849)

27. Shi C, Zhou H, Li X, Cai Y. A Retrospective Analysis on Two-week Short-course Pre-operative Radiotherapy in Elderly Patients with Resectable Locally Advanced Rectal Cancer. Sci Rep. 2016;6:37866.(IF=5.578)

28. Li Y, Gong J, Zhang Q, Lu Z, Gao J, Li Y, Cao Y, Shen L. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer. Br J Cancer. 2016;114(2):138-45.(IF=5.569)

29. Wang Y, Xu Y, Chen J, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer. Int J Cancer. 2016;138(2):489-96.(IF=5.531)

30. Liu Y, Zhang C, Gao W, Wang L, Pan Y, Gao Y, et al. Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology. Sci Rep. 2016;6:35427.(IF=5.228)

31. Wang S, Xiong H, Yan S, Wu N, Lu Z. Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology. Sci Rep. 2016;6:26156.(IF5.228)

32. Yang W, Li Y, Ning T, Cai H, Chen Z, Dong Y, Ke Y. Polymorphisms in the 5' upstream regulatory region of p21(WAF1/CIP1) and susceptibility to oesophageal squamous cell carcinoma. Sci Rep. 2016;6:22564.(IF=5.228)

33. Liu F, Deng Q, Zhang C, Pan Y, Liu Y, He Z, Sun M, Liu M, Li J, Li X, Zhang C, Hang D, Ning T, Guo C, Liang Y, Xu R, Zhang L, Cai H, Ke Y. Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional study. Sci Rep. 2016;6:26343.(IF=5.228)

34. Huang D, Duan H, Huang H, Tong X, Han Y, Ru G, Qu L, Shou C, Zhao Z. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Sci Rep. 2016;6:20502.(IF=5.228)

35. Che L, Fan B, Pilo MG, Xu Z, Liu Y, Cigliano A, Cossu A, Palmieri G, Pascale RM, Porcu A, Vidili G, Serra M, Dombrowski F, Ribback S, Calvisi DF, Chen X. Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans. Oncogenesis. 2016;5(12):e274.(IF=5.021)

36. Ma D, Wang Z, Yang L, Mu X, Wang Y, Zhao X, Li J, Lin D. Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative. Oncotarget. 2016;7(39):64410-64420.(IF=5.008)

37. Ling Y, Yang X, Li W, Li Z, Yang L, Qiu T, Guo L, Dong L1 Li L, Ying J, Lin D. Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer. Oncotarget. 2016;7(33):52862-52869.(IF=5.008)

38. Li Z, Xing X, Shan F, Li S, Li Z, Xiao A, Xing Z, Xue K, Li Z, Hu Y, Jia Y, Miao R, Zhang L, Bu Z, Wu A, Ji J. ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. Oncotarget. 2016;7(34):55449-55457.(IF=5.008)

39. Yu L, Fan Z, Fang S, Yang J, Gao T, Sim?es BM, Eyre R, Guo W, Clarke RB. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling. Oncotarget. 2016;7(22):33055-68.(IF=5.008)

40. Hou MM, Wang Z, Janku F, Piha-Paul S, Naing A, Hong D, Westin S, Coleman RL, Sood AK, Tsimberidou AM, Subbiah V, Wheler J, Zinner R, Lu K, Meric-Bernstam F, Fu S. Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. Oncotarget. 2016;7(23):35132-43.(IF=5.008)

41. Wang X., Yang Z., Lin B. Zhang Y, Zhai S, Zhao Q, Xie Q, Liu F, Han X, Li J, Ouyang T. Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study. Oncotarget. 2016. 7, 25, 38810-38821(IF=5.008)

42. Yang X, Zhuo M, Ye X, Bai H, Wang Z, Sun Y, Zhao J, An T, Duan J, Wu M, Wang J. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer. Oncotarget. 2016;7(15):20810-24. (IF=5.008)

43. Shen LY, Wang H, Dong B, Yan WP, Lin Y, Shi Q, Chen KN. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling. Oncotarget. 2016;7(4):4531-41. (IF=5.008)

44. Han SY, Han HB, Tian XY, Sun H, Xue D, Zhao C, Jiang ST, He XR, Zheng WX, Wang J, Pang LN, Li XH, Li PP. MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma. Oncotarget. 2016;7(27):42461-42473. (IF=5.008)

45. Liu Z, Zhou J, Gu L, Deng D. Significant impact of amount of PCR input templates on various PCR-based DNA methylation analysis and countermeasure. Oncotarget. 2016;7(35):56447-56455(IF=5.008)

46. Zhang Y, Zhang XR, Park JL, Kim JH, Zhang L, Ma JL, Liu WD, Deng DJ, You WC, Kim YS, Pan KF. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA. Oncotarget. 2016;7(24):37132-37144. (IF=5.008)

47. Wang A, Cui M, Qu H, Di J, Wang Z, Xing J, Wu F, Wu W, Wang X, Shen L, Jiang B, Su X. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab. Oncotarget. 2016;7(46):75293-75306(IF=5.008)

48. Sheng X, Chi Z, Cui C, Si L, Li S, Tang B, Mao L, Lian B, Wang X, Yan X, Guo J. Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis. Oncotarget. 2016;7(19):27044-54. (IF=5.008)

49. Yuan J, Zhang J, Zhu Y, Li N, Tian T, Li Y, Li Y, Li Z, Lai Y, Gao J, Shen L1. Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significance. Oncotarget. 2016;7(26):39671-39679(IF=5.008)

50. Yuan J, Li Y, Tian T, Li N, Zhu Y, Zou J, Gao J, Shen L. Risk prediction for early-onset gastric carcinoma: a case-control study of polygenic gastric cancer in Han Chinese with hereditary background. Oncotarget. 2016;7(23):33608-15. (IF=5.008)

51. Gao J, Li J, Li Y, Li Z, Gong J, Wu J, Liu N, Dong B, Qi C, Li J, Shen L. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors. Oncotarget. 2016;7(21):30241-9. (IF=5.008)

52. Qiao J, Liu Z, Yang C, Gu L, Deng D. SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent manner. Oncotarget. 2016;7(29):46088-46099(IF=5.008)

53. Li C, Yu W, Fan J, Li G, Tao X, Feng Y, Sun R. Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers. Oncotarget. 2016;7(31):49930-49938(IF=5.008)

54. Liu W, Zhou JG, Sun Y, Zhang L, Xing BC. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis. Oncotarget 2016:24(7):37277-37287(IF=5.008)

55. Liu C, Shi B, Hao C, Wang Q, Lv Q, Xing N, Shou J, Qu L, Gao Y, Qin C, Zhao J, Shou C. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer. Oncotarget 2016;7(28):43432-43441(IF=5.008)

56. Han Y, Lian S, Cui X, Meng K, Gy?rffy B, Jin T, Huang D. Potential options for managing LOX+ ER- breast cancer patients. Oncotarget. 2016;7(22):32893-32901(IF=5.008)

57. Li S, Li Z, Guo T, Xing XF, Cheng X, Du H, Wen XZ, Ji JF. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer. Oncotarget. 2016;7(5):6266-80. (IF=5.008)

58. Li N, Zhang QY, Zou JL, Li ZW, Tian TT, Dong B, Liu XJ, Ge S, Zhu Y, Gao J, Shen L. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Oncotarget. 2016;7(4):4817-28. (IF=5.008)

59. Wu L, Yao L, Zhang H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Yin CC, Xie Y. A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget. 2016;7(4):5042-52. (IF=5.008)

60. Zhou J, Li M, Yu W, Li W, Wang J, Xiang X, Li G, Pan X, Lei D. AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival. Oncotarget. 2016;7(12):14628-38. (IF=5.008)

61. Liu Y, Lu Z, Xu R, Ke Y. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget. 2015;7(5):5852-5864(IF=5.008)

62. Liu Y, Yang W, Pan Y, Ji J, Lu Z, Ke Y. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC). Oncotarget. 2015;7(4):4903-4914. (IF=5.008)

63. Kong JF, Du J, Wang YL, Yang MZ, Gao JC, Wei XF1, Fang WG, Zhan J, Zhang HQ. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells. Oncotarget 2016 (IF=5.008)

64. Zhang C, Tian W, Meng L, Qu L, Shou C. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. J Mol Med (Berl). 2016;94(4):401-15.(IF=4.855)

65. Cui C, Lu Z, Yang L, Gao Y, Liu W, Gu L, Yang C, Wilson J, Zhang Z, Xing B, Deng D, Sun ZS. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas. Mol Carcinog. 2016;55(7):1163-74.(IF=4.722)

66. Wang X, Liu Y, Shao D, Qian Z, Dong Z, Sun Y, Xing X, Cheng X, Du H, Hu Y, Li Y, Li L, Dong B, Li Z, Wu A, Wu X, Bu Z, Zong X, Zhu G, Ji Q, Wen XZ, Zhang LH, Ji JF. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer. 2016;19(1):116-27.(IF=4.404)

67. Wang J, Xu R, Li J, Bai Y, Liu T, Jiao S, Dai G, Xu J, Liu Y, Fan N, Shu Y, Ba Y, Ma D, Qin S, Zheng L, Chen W, Shen L. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric Cancer. 2016;19(1):234-44. (IF=4.404)

68. Zhao Y, Luo A, Li S, Zhang W, Chen H, Li Y, Ding F, Huang F, Liu Z. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner. J Biol Chem. 2016;291(13):6831-42.(IF=4.258)

69. Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat. 2016;158(3):455-62.(IF=4.085)

70. Zhou Y, Ouyang T, Xie Y, Wang T, Fan Z, He Y, Lu A, Liu Y, Li J. A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Breast Cancer Res Treat. 2016;157(3):527-34. (IF=4.085)

71. Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat. 2016;156(3):441-5. (IF=4.085)

72. Su X, Chen WJ, Xiao SW, Li XF, Xu G, Pan JJ, Zhang SW. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer. Hum Gene Ther. 2016;27(12):1008-1014.(IF=4.062)

73. Zhang P, Ma Y, Lv C, Huang M, Li M, Dong B, Liu X, An G, Zhang W, Zhang J, Zhang L, Zhang S, Yang Y. Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy. Cancer Sci. 2016;107(11):1563-1571.(IF=3.896)

74. Lu M, Wang X, Shen L, Jia J, Gong J, Li J, Li J, Li Y, Zhang X, Lu Z, Zhou J, Zhang X. Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase II trial. Cancer Sci. 2016;107(4):486-90. (IF=3.896)

75. Zhang Y, Zeng HM, Nie XR, Zhang L, Ma JL, Li JY, Pan KF, You WC. Alterations of Cyclooxygenase-2 Methylation Levels Before and After Intervention Trial to Prevent Gastric Cancer in a Chinese Population. Cancer Prev Res. 2016;9(6):484-90.(IF=3.887)

76. Pan HD, Peng YF, Wang L, Li M, Yao YF, Zhao J, Zhan TC, Gu J. Risk Factors for Nonclosure of a Temporary Defunctioning Ileostomy Following Anterior Resection of Rectal Cancer. Dis Colon Rectum. 2016;59(2):94-100.(IF=3.739)

77. Li Z, Shan F, Wang Y, Li S, Jia Y, Zhang L, Yin D, Ji J. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results. Surg Endosc. 2016;30(10):4265-71.(IF=3.54)

78. Yong W. Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type. Hematol Oncol. 2016;34(2):61-68.(IF=3.494)

79. Yu W, Cao X, Xu G, Song Y, Li G, Zheng H, Zhang N. Potential role for carbon nanoparticles to guide central neck dissection in patients with papillary thyroid cancer. Surgery. 2016;160(3):755-61.(IF=3.309)

80. Min L, Zhang C, Ma R, Li X, Yuan H, Li Y, Chen R, Liu C, Guo J, Qu L, Shou C. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients. BMC Cancer. 2016;16:717.(IF=3.265)

81. Min L, Zhang C, Ma R, Li X, Yuan H, Li Y, Chen R, Liu C, Guo J, Qu L, Shou C. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients. BMC Cancer. 2016;16:717. (IF=3.265)

82. Zheng Z, Zhang Y, Zhang L, Li Z, Wu X, Liu Y, Bu Z, Ji J. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients. BMC Cancer. 2016;16:92. (IF=3.265)

83. Zhu XG, Li YH, Li XF, Cai Y. Intensity-modulated radiation therapy for pelvic oligo-recurrence from rectal cancer: long-term results from a single institution. Am J Transl Res. 2016;8(2):1265-72.(IF=3.146)

84. Liu WP, Wang XP, Zheng W, Ping LY, Zhang C, Wang GQ, Song YQ, Zhu J. Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma. Leuk Lymphoma. 2016;57(6):1355-62.(IF=3.093)

85. Wang L, Li YH, Cai Y, Zhan TC, Gu J. Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years. Clin Colorectal Cancer. 2016;15(2):152-7.(IF=3.09)

86. Liu M, Zhang C, Cai H, Liu F, Liu Y, Li J, et al. The Willingness to Change Risky Health Behaviors among Chinese Rural Residents: What We Learned from a Population-Based Esophageal Cancer Cohort Study. PLoS One. 2016;11(8):e0161999.(IF=3.057)

87. Cheng X, Tian X, Wu X, Xing X, Du H, Zhou C, Zhang Q, Hao C, Wen X, Ji J. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers. PLoS One. 2016;11(7):e0158715. (IF=3.057)

88. Wei Q, Wang X, Gao J, Li J, Li J, Qi C, Li Y, Li Z, Shen L. Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component. PLoS One. 2016;11(6):e0156659. (IF=3.057)

89. Tian T, Gao J, Li N, Li Y, Lu M, Li Z, et al. Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors. PLoS One. 2016;11(5): e0154679. (IF=3.057)

90. Li Yang, Ya-Jun Wang, Li-Yuan Zheng, Yu-Mian Jia, Yi-Lin Chen, Lan Chen, Dong-Ge Liu, Xiang-Hong Li, Hong-Yan Guo, Ying-Li Sun, Xin-Xia Tian, Wei-Gang Fang. Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women. PLoS One. 11 (5): e0155270(3.057)

91. Cao Y, Liu Y, Yang X, Liu X, Han N, Zhang K, Lin D. Estimation of the Survival of Patients With Lung Squamous Cell Carcinoma Using Genomic Copy Number Aberrations. Clin Lung Cancer. 2016;17(1):68-74.(IF=3.03)

92. Jia J, Song Y, Lin N, Liu W, Ping L, Zheng W, Wang X, Xie Y, Tu M, Zhang C, Ying Z, Deng L, Ding N, Zhu J. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome. Ann Hematol. 2016;95(12):2023-2031(IF=3.022)

93. Wang Y, Wu N, Zheng Q, Wang J, Yan S, Li S, Liu Y, Chen J, Yang Y. Prediction of Surgical Outcome by Modeling Based on Risk Factors of Morbidity After Pulmonary Resection for Lung Cancer in Older Adults. Ann Thorac Surg. 2016;102(3):971-8.(IF=3.021)

94. Yi H, Ji D, Zhan T, Yao Y, Li M, Jia J, Li Z, Gu J. Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma. Int J Oncol. 2016;49(4):1415-26.(IF=3.018)

95. Ma Y, Li M, Si J, Xiong Y, Lu F, Zhang J, Zhang L, Zhang P, Yang Y. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer. Int J Oncol. 2016;48(6):2349-58. (IF=3.018)

96. Lan F, Yang Y, Han J, Wu Q, Yu H, Yue X. Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression. Int J Oncol. 2016;48(2):559-68. (IF=3.018)